Sutro Biopharma (STRO) EBT (2017 - 2025)
Sutro Biopharma (STRO) reported EBT of -$46.8 million for Q4 2025, up 33.16% on a YoY basis from -$35.2 million in Q4 2024, and up 17.61% sequentially from -$56.9 million in Q3 2025.
Sutro Biopharma (STRO) EBT (2017 - 2025) Analysis & Trends
Sutro Biopharma (STRO) has 9 years of EBT data on file, last reported at -$46.8 million in Q4 2025.
- For the quarter ending Q4 2025, EBT rose 33.16% year-over-year to -$46.8 million; the trailing twelve-month figure through Dec 2025 stood at -$182.8 million (up 18.77% YoY), and the FY2025 full-year result was -$191.2 million, up 15.07% from the prior year.
- EBT climbed to -$46.8 million in Q4 2025, from -$56.9 million in the prior quarter.
- In the past five years, EBT ranged from a high of $46.9 million in Q4 2023 to a low of -$70.1 million in Q4 2024.
- A 5-year average of -$35.4 million and a median of -$38.7 million in 2022 frame the typical range for EBT.
- Across the five-year window, EBT plunged 282.18% in 2022 and surged 235.49% in 2023, its largest moves.
- Tracing STRO's EBT over 5 years: stood at -$38.1 million in 2021, then rose by 9.26% to -$34.6 million in 2022, then surged by 235.49% to $46.9 million in 2023, then tumbled by 249.53% to -$70.1 million in 2024, then soared by 33.16% to -$46.8 million in 2025.
- Business Quant data shows STRO's EBT at -$46.8 million in Q4 2025, -$56.9 million in Q3 2025, and -$11.5 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.31 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 259.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 438.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Sutro Biopharma | 192.86 Mn | 51.43 Mn | - | -46.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -46.84 Mn |
| Sep 30, 2025 | -56.86 Mn |
| Jun 30, 2025 | -11.52 Mn |
| Mar 31, 2025 | -67.63 Mn |
| Dec 31, 2024 | -70.09 Mn |
| Sep 30, 2024 | -48.79 Mn |
| Jun 30, 2024 | -48.01 Mn |
| Mar 31, 2024 | -58.21 Mn |
| Dec 31, 2023 | 46.87 Mn |
| Sep 30, 2023 | -47.45 Mn |
| Jun 30, 2023 | -38.37 Mn |
| Mar 31, 2023 | -49.66 Mn |
| Dec 31, 2022 | -34.59 Mn |
| Sep 30, 2022 | -19.49 Mn |
| Jun 30, 2022 | -23.51 Mn |
| Mar 31, 2022 | -39.11 Mn |
| Dec 31, 2021 | -38.13 Mn |
| Sep 30, 2021 | -30.90 Mn |
| Jun 30, 2021 | -6.15 Mn |
| Mar 31, 2021 | -19.67 Mn |